|
Volumn 141, Issue 6, 2014, Pages 772-773
|
What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
APOLIPOPROTEIN B;
C REACTIVE PROTEIN;
CHOLESTEROL;
CREATINE KINASE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
ADULT;
ALBUMINURIA;
AMERICAN COLLEGE OF CARDIOLOGY;
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;
CHOLESTASIS;
CHOLESTEROL BLOOD LEVEL;
CLINICAL LABORATORY;
EDITORIAL;
GLOMERULUS FILTRATION RATE;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPOTHYROIDISM;
LIPID ANALYSIS;
MEDICAL SOCIETY;
NEPHROTIC SYNDROME;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
ADULT;
AGED;
AMERICAN HEART ASSOCIATION;
CARDIOLOGY;
CARDIOVASCULAR DISEASES;
CHOLESTEROL;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
LABORATORIES;
MIDDLE AGED;
PRACTICE GUIDELINES AS TOPIC;
SOCIETIES, MEDICAL;
UNITED STATES;
|
EID: 84904480222
PISSN: 00029173
EISSN: 19437722
Source Type: Journal
DOI: 10.1309/AJCPED9X7RNMYAEQ Document Type: Editorial |
Times cited : (3)
|
References (10)
|